MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0041874
Lustre Pharmaceuticals Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.03 Cr
▲ 8% YoY
Net profit · FY 2025
₹54.13 Lakh
Net margin 5.4%
EBITDA · FY 2025
₹1.15 Cr
EBITDA margin 11.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹6.89 Cr
Satisfied ₹7.94 Cr
Company age
23 yrs
Est. 2003
Directors on board
4
As per MCA filings
About Lustre Pharmaceuticals Private Limited
Data last updated:
Lustre Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 March 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2003PTC042154. Its GSTIN is 24AAACL9048A1ZV (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Lustre Pharmaceutical Private Limited. It is led by directors including Jatinkumar Kantilal Modi and Sanjaykumar Babulal Modi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.03 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹54.13 Lakh (net margin 5.4%) and EBITDA of ₹1.15 Cr (EBITDA margin 11.4%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 8% over five years.
The company is associated with 1 brand: Lustre Pharmaceutical. As per MCA filings, the company has open charges of ₹6.89 Cr and satisfied charges of ₹7.94 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 1 case is pending.
Lustre Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0041874). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lustrepharma.in.
Company details
CIN U24231GJ2003PTC042154
Registration Number 042154
Incorporation Date 24 March 2003
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0041874
CIN history
Lustre Pharmaceuticals has one previous CIN (Corporate Identification Number): U23231GJ2003PTC042154. The current CIN is U24231GJ2003PTC042154, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231GJ2003PTC042154 | Current |
| U23231GJ2003PTC042154 | Previous |
Key People
Jatinkumar Kantilal Modi Director Sanjaykumar Babulal Modi Director Hirenkumar Knatilal Modi Director Recognitions & Rankings of Lustre Pharmaceuticals
Contact details
Lustre Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is lustrepharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address15 Barcelona Industrial Estate Sardar Patel Ring Road Odhav Circle Od, Hav, Ahmedabad, Gujarat, India – 382415
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lustre Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Lustre Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Lustre Pharmaceuticals operates one associated brand: Lustre Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical tablets, capsules, syrups, and injections for health needs. | lustrepharma.com |
Business activity
The main business activity of Lustre Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lustre Pharmaceuticals Private Limited, buy the company report.
Financials of Lustre Pharmaceuticals Private Limited
FY 2025 filings availableLustre Pharmaceuticals Private Limited reported revenue of ₹10.03 Cr (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹10.03 Cr ▲ 8%
Net profit · FY 2025
₹54.13 Lakh margin 5.4%
EBITDA · FY 2025
₹1.15 Cr margin 11.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 4%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 4%
5 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 8% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.15 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹54.13 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.4% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lustre Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lustre Pharmaceuticals Private Limited
Lustre Pharmaceuticals has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jatinkumar Kantilal Modi | Director | 24 Mar 2003 | 23 Years 7 Months | Current |
| Sanjaykumar Babulal Modi Also directs: Lustre Energy LLP, Shree Sundha Gold Jewellers LLP, Shreesundha Construction LLP and 5 more | Director | 20 Jun 2015 | 11 Years 4 Months | Current |
| Hirenkumar Knatilal Modi | Director | 24 Mar 2003 | 23 Years 7 Months | Current |
| Shitalben Sanjykumar Modi | Director | 24 Mar 2003 | 23 Years 7 Months | Current |
Auditor
Lustre Pharmaceuticals Private Limited is audited by M S KHATRI & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M S KHATRI & ASSOCIATES | FY 2022 | 127049W |
Shareholding
The shareholding of Lustre Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lustre Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹6.89 Cr
Satisfied charges
₹7.94 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Aug 2025 | 101140769 | Others | ₹2.65 Cr | Open | |
| 18 Nov 2024 | 101004929 | Hdfc Bank Limited | ₹2 Cr | Open | |
| 24 Sep 2024 | 100978829 | Hdfc Bank Limited | ₹2.25 Cr | Open | |
| 27 Jul 2022 | 100598270 | Others | ₹1.8 Cr | Satisfied | |
| 10 Sep 2020 | 100371080 | Others | ₹10.89 Lakh | Satisfied |
To see the full charge records of Lustre Pharmaceuticals Private Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Lustre Pharmaceuticals Private Limited has 4 court cases on record: 4 filed by Lustre Pharmaceuticals. 1 case is pending and 3 are disposed.
Total cases
4
Filed by the company
4
Pending
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against an individual | Pending |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed by the company against an individual | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against an individual | Disposed |
| District court, GANDHINAGAR, Gujarat | Criminal complaint | Filed by the company against an individual | Disposed |
To see the full case history of Lustre Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lustre Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lustre Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACL9048A1ZV | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lustre Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lustre Pharmaceuticals Private Limited has 14 board changes on record since 2003: 4 appointments and 10 cessations. The latest: Sanjaykumar Babulal Modi ceased to be Additional Director on 30 Sep 2015.
AGM
Lustre Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 265.00 Lakh with Charge ID 101140769 was registered on 13 Aug 2025.
Filing
Lustre Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Hdfc Bank Limited of Rs. 199.52 Lakh registered on 18 Nov 2024 with Charge ID 101004929 was modified on 25 Mar 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 224.85 Lakh registered on 24 Sep 2024 with Charge ID 100978829 was modified on 26 Nov 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 199.52 Lakh with Charge ID 101004929 was registered on 18 Nov 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 224.85 Lakh with Charge ID 100978829 was registered on 24 Sep 2024.
Charges
A charge registered on 27 Jul 2022 via Charge ID 100598270 with Others was fully satisfied on 18 Nov 2023.
Charges
A charge registered on 10 Sep 2020 via Charge ID 100371080 with Others was fully satisfied on 18 Nov 2023.
Charges
A charge registered on 23 May 2018 via Charge ID 100186052 with Others was fully satisfied on 18 Nov 2023.
Charges
A charge with Others amounted to Rs. 180.00 Lakh with Charge ID 100598270 was registered on 27 Jul 2022.
Charges
A charge with Others of Rs. 480.00 Lakh registered on 23 May 2018 with Charge ID 100186052 was modified on 05 Jul 2022.
24 earlier events are in the company report.
Frequently asked questions
Lustre Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 March 2003 (23+ years old) and is registered under CIN U24231GJ2003PTC042154.
Lustre Pharmaceuticals has 4 current directors:
- Jatinkumar Kantilal Modi - Director
- Sanjaykumar Babulal Modi - Director
- Hirenkumar Knatilal Modi - Director
- Shitalben Sanjykumar Modi - Director
The latest financial statements of Lustre Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lustre Pharmaceuticals is 24AAACL9048A1ZV, registered in Gujarat.
The CIN (Corporate Identification Number) of Lustre Pharmaceuticals is U24231GJ2003PTC042154. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lustre Pharmaceuticals has 4 court cases on record: 4 filed by the company. 1 is pending.
Lustre Pharmaceuticals was incorporated on 24 March 2003, making it 23+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Sanjaykumar Babulal Modi ceased to be Additional Director on 30 Sep 2015. Babulal Ravchand Modi ceased to be Director on 20 Jun 2015. Sanjaykumar Babulal Modi was appointed as Director on 20 Jun 2015. Lustre Pharmaceuticals has 14 board changes on record in total.
Yes, Lustre Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0041874).
Lustre Pharmaceuticals can be reached through the website lustrepharma.in. Its registered office is in Ahmedabad, Gujarat, India.